SEER Stock Price, Seer, Inc. Quote, Chart

Market Summary

USD1.75-0.06

Delayedas of 24 Apr 2024, 11:06 am

-3.31%

SEER Stock Price

View Fullscreen

SEER RSI Chart

SEER Valuation

Market Cap

115.6M

Price/Earnings (Trailing)

-1.34

Price/Sales (Trailing)

6.94

Price/Free Cashflow

-1.74

SEER Price/Sales (Trailing)

SEER Profitability

Operating Margin

51.05%

Return on Equity

-21.74%

Return on Assets

-19.78%

Free Cashflow Yield

-57.43%

SEER Fundamentals

SEER Revenue

Revenue (TTM)

16.7M

Rev. Growth (Yr)

-3.63%

Rev. Growth (Qtr)

6.63%

SEER Earnings

Earnings (TTM)

-86.3M

Earnings Growth (Yr)

20.98%

Earnings Growth (Qtr)

15.6%

Breaking Down SEER Revenue

52 Week Range

1.745.65

(Low)(High)

Last 7 days

3.4%

Last 30 days

-4.7%

Last 90 days

7.7%

Trailing 12 Months

-51.7%

How does SEER drawdown profile look like?

SEER Financial Health

Current Ratio

25

SEER Investor Care

Shares Dilution (1Y)

2.27%

Diluted EPS (TTM)

-1.36

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	16.2M	16.6M	16.8M	16.7M
2022	9.9M	12.2M	14.0M	15.5M
2021	2.1M	3.6M	5.1M	6.6M
2020	0	0	0	656.0K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Seer, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 07, 2024	farokhzad omid	sold	-107,421	2.0323	-52,857	ceo and chair
Feb 22, 2024	horn david r.	sold	-20,024	1.5787	-12,684	president & cfo
Feb 22, 2024	kogan elona	sold	-20,024	1.5787	-12,684	chief legal officer
Feb 06, 2024	horn david r.	acquired	-	-	165,038	president & cfo
Feb 06, 2024	farokhzad omid	acquired	-	-	529,634	ceo and chair
Feb 06, 2024	kogan elona	acquired	-	-	123,153	chief legal officer
Feb 05, 2024	horn david r.	sold	-6,014	1.667	-3,608	president and cfo
Dec 04, 2023	kogan elona esq.	sold	-13,869	1.6951	-8,182	chief legal officer
Nov 02, 2023	farokhzad omid	acquired	6,070	0.04	151,764	ceo, president and chair
Aug 23, 2023	farokhzad omid	bought	97,968	2.4492	40,000	ceo, president and chair

Which funds bought or sold SEER recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	MetLife Investment Management, LLC	sold off	-100	-69,288	-	-%
Apr 15, 2024	Palumbo Wealth Management LLC	added	828	157,632	177,120	0.08%
Apr 05, 2024	CWM, LLC	new	-	-	-	-%
Apr 05, 2024	GAMMA Investing LLC	unchanged	-	71.00	745	-%
Mar 11, 2024	VANGUARD GROUP INC	added	5.09	-425,182	5,064,630	-%
Mar 01, 2024	GOLDMAN SACHS GROUP INC	added	120	316,500	653,998	-%
Feb 28, 2024	AMERICAN INTERNATIONAL GROUP, INC.	reduced	-0.4	-8,130	56,539	-%
Feb 26, 2024	Virtu Financial LLC	new	-	28,000	28,000	-%
Feb 16, 2024	GSA CAPITAL PARTNERS LLP	new	-	32,000	32,000	-%
Feb 16, 2024	PRICE T ROWE ASSOCIATES INC /MD/	reduced	-96.97	-2,425,000	67,000	-%

Are Funds Buying or Selling SEER?

Are funds buying SEER calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own SEER

No. of Funds

Unveiling Seer, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 10, 2024	fmr llc	-	0	SC 13G/A
Feb 14, 2024	farokhzad omid	9.9%	6,513,255	SC 13G/A
Feb 13, 2024	softbank group corp.	8.6%	5,135,383	SC 13G/A
Feb 13, 2024	vanguard group inc	4.37%	2,610,633	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 09, 2024	capital world investors	3.4%	2,056,000	SC 13G/A
Jan 24, 2024	blackrock inc.	9.7%	5,791,042	SC 13G/A
Jan 03, 2024	schindel yair chaim	6.44%	4,112,235	SC 13G/A
Dec 11, 2023	fmr llc	-	0	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	2.2%	1,302,700	SC 13G/A

Recent SEC filings of Seer, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 10, 2024	SC 13G/A	Major Ownership Report
Mar 12, 2024	4	Insider Trading
Mar 06, 2024	S-8	Employee Benefits Plan
Mar 04, 2024	10-K	Annual Report
Feb 29, 2024	8-K	Current Report
Feb 23, 2024	4	Insider Trading
Feb 23, 2024	4	Insider Trading
Feb 23, 2024	4	Insider Trading
Feb 14, 2024	SC 13G/A	Major Ownership Report
Feb 13, 2024	SC 13G/A	Major Ownership Report

Peers (Alternatives to Seer, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	41.2B	6.8B	2.33%	-21.90%	-8.74	6.02	-64.45%	-156.37%
HILS	22.4B	152.6K	-0.77%	465779.94%	-2.4K	146.8K	-	-9.98%
ALNY	18.4B	1.8B	-0.30%	-28.67%	-41.79	10.06	76.23%	61.08%
BMRN	17.4B	2.4B	8.14%	-4.26%	103.61	7.18	15.42%	18.43%
INCY	11.6B	3.7B	-9.39%	-31.39%	19.4	3.14	8.87%	75.42%
MID-CAP
APLS	5.9B	396.6M	-12.04%	-45.12%	-11.11	14.81	425.83%	18.94%
BBIO	4.5B	-	-13.93%	67.39%	-6.85	60.35	54.84%	-34.79%
AXSM	3.5B	270.6M	-9.40%	-0.33%	-14.47	12.79	440.80%	-27.84%
ARWR	2.9B	240.7M	-12.61%	-20.79%	-9.93	12.18	-1.03%	-92.09%
ACAD	2.8B	726.4M	-6.74%	-16.88%	-45.01	3.8	40.45%	71.62%
SMALL-CAP
CPRX	1.7B	398.2M	-6.36%	-10.84%	24.31	4.36	85.90%	-14.05%
NVAX	587.8M	983.7M	-10.64%	-48.02%	-1.08	0.6	-50.36%	17.16%
CRBP	396.0M	881.7K	8.01%	271.09%	-8.88	466.16	-77.61%	-5.33%
INO	242.4M	4.9M	-10.76%	0.48%	-1.79	49.8	-54.97%	51.71%
IBIO	6.7M	2.1M	76.15%	62.71%	-0.25	2.14	-13.45%	66.37%

Seer, Inc. News

Latest updates

Seer, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Revenue	6.6%	4,438	4,162	4,008	4,053	4,605	3,955	3,621	3,312	3,066	2,155	1,334	835	336	72.00	71.00	177
Cost Of Revenue	21.5%	2,437	2,006	1,727	1,985	2,310	2,010	2,012	2,068	1,633	986	586	-	-	-	-	-
Gross Profit	-7.2%	2,001	2,156	2,281	2,068	2,295	1,945	1,609	1,244	1,433	1,169	748	62.00	-	72.00	71.00	-
Operating Expenses	-13.5%	24,233	28,001	30,222	29,513	27,244	27,011	25,043	25,030	21,307	19,600	17,419	16,560	13,377	8,488	6,438	6,002
S&GA Expenses	-11.5%	13,068	14,769	16,074	15,039	14,614	15,447	14,172	14,298	13,092	11,855	10,484	10,333	7,955	3,726	1,902	1,780
R&D Expenses	-15.6%	11,165	13,232	14,148	14,474	12,630	11,564	10,871	10,732	8,215	7,745	6,935	6,227	5,422	4,762	4,536	4,222
Income Taxes	-	-	-	-	-	-	-	-	-	40.00	164	-	-	-	-	-	-
Net Income	15.6%	-17,799	-21,088	-23,431	-23,959	-22,525	-23,980	-22,815	-23,646	-19,739	-18,385	-16,616	-16,429	-12,936	-8,229	-6,117	-5,493
Net Income Margin	4.2%	-5.18*	-5.41*	-5.65*	-5.75*	-6.00*	-6.46*	-6.96*	-7.94*	-10.76*	-12.55*	-14.91*	-20.37*	-49.96*	-	-	-
Free Cashflow	35.4%	-12,029	-18,612	-16,281	-19,452	-19,229	-16,059	-15,526	-20,231	-13,703	-11,401	-12,455	-15,710	-5,612	-6,355	-7,258	-6,137

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet													(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	-1.9%	436	445	461	473	488	500	516	527	539	528	537	546	442
Current Assets	-4.5%	331	346	335	367	435	450	467	457	412	514	525	536	433
Cash Equivalents	-10.7%	32.00	36.00	56.00	48.00	53.00	69.00	80.00	226	233	332	371	446	334
Inventory	6.3%	4.00	4.00	5.00	4.00	5.00	6.00	7.00	4.00	4.00	3.00	3.00	2.00	1.00
Net PPE	2.1%	22.00	22.00	22.00	19.00	19.00	16.00	15.00	14.00	13.00	13.00	11.00	9.00	8.00
Liabilities	0.5%	39.00	39.00	43.00	40.00	41.00	42.00	44.00	41.00	36.00	13.00	11.00	10.00	11.00
Current Liabilities	5.6%	13.00	13.00	16.00	12.00	13.00	14.00	15.00	11.00	13.00	10.00	8.00	7.00	8.00
Shareholder's Equity	-2.2%	397	406	418	433	447	458	472	486	503	515	526	536	432
Retained Earnings	-6.2%	-305	-288	-266	-243	-219	-197	-173	-150	-126	-106	-88.40	-71.79	-55.36
Additional Paid-In Capital	1.1%	703	695	687	677	668	657	648	639	630	622	614	608	487
Accumulated Depreciation	13.7%	13.00	11.00	10.00	8.00	8.00	7.00	6.00	6.00	5.00	4.00	3.00	3.00	2.00
Shares Outstanding	-0.2%	64.00	64.00	64.00	64.00	62.00	63.00	62.00	62.00	62.00	61.00	61.00	60.00	59.00
Float	-	-	-	232	-	-	-	426	-	-	-	1,600	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1
Cashflow From Operations	29.3%	-10,190	-14,411	-15,133	-19,331	-14,256	-13,373	-14,000	-19,151	-12,369	-8,756	-10,350	-14,872	-5,485	-5,490	-4,779	-5,074
Share Based Compensation	-8.6%	7,614	8,334	9,752	8,724	8,160	9,073	8,378	8,062	6,671	6,786	6,431	6,039	4,784	1,177	808	579
Cashflow From Investing	208.6%	6,111	-5,625	22,939	14,479	-2,711	2,250	-133,177	10,920	-87,489	-31,126	-64,146	11,883	5,273	-50,102	7,319	2,952
Cashflow From Financing	550.0%	182	28.00	212	30.00	2,106	169	866	752	1,269	609	-411	115,167	316,091	355	54,995	45.00
Buy Backs	-100.0%	-	13.00	-	-	-	-	20.00	-	-	29.00	-	-	7.00	3.00	-	-

SEER Income Statement

2023-12-31

Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Revenue:
Total revenue	$ 16,661	$ 15,493
Cost of revenue:
Total cost of revenue	8,155	8,400
Gross profit	8,506	7,093
Operating expenses:
Research and development	53,019	45,797
Selling, general and administrative	58,950	58,531
Total operating expenses	111,969	104,328
Loss from operations	(103,463)	(97,235)
Other income (expense):
Interest income	17,764	4,602
Other expense	(578)	(333)
Total other income	17,186	4,269
Net loss	(86,277)	(92,966)
Other comprehensive gain (loss):
Unrealized gain (loss) on available-for-sale securities	1,059	(715)
Comprehensive loss	$ (85,218)	$ (93,681)
Net loss per share attributable to common shareholders, basic (in usd per share)	$ (1.35)	$ (1.49)
Net loss per share attributable to common shareholders, diluted (in usd per share)	$ (1.35)	$ (1.49)
Weighted-average common shares outstanding, basic	63,850,490	62,433,613
Weighted-average common shares outstanding, diluted	63,850,490	62,433,613
Nonrelated Party \| Product
Revenue:
Total revenue	$ 8,506	$ 8,557
Cost of revenue:
Total cost of revenue	5,398	5,459
Nonrelated Party \| Service
Revenue:
Total revenue	2,016	913
Cost of revenue:
Total cost of revenue	685	495
Nonrelated Party \| Grant and other
Revenue:
Total revenue	1,479	808
Cost of revenue:
Total cost of revenue	642	457
Related Party \| Product
Revenue:
Total revenue	4,660	5,215
Cost of revenue:
Total cost of revenue	$ 1,430	$ 1,989

SEER Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 32,499	$ 53,208
Short-term investments	283,725	368,031
Other receivables	1,326	899
Inventory	4,491	4,627
Prepaid expenses and other current assets	3,082	2,098
Total current assets	330,513	434,982
Long-term investments	56,858	5,157
Operating lease right-of-use assets	25,177	27,003
Property and equipment, net	22,193	19,408
Restricted cash	524	524
Other assets	1,004	855
Total assets	436,269	487,929
Current liabilities:
Accounts payable	1,370	2,104
Accrued expenses	9,212	8,298
Deferred revenue	206	133
Operating lease liabilities, current	2,295	1,842
Other current liabilities	139	207
Total current liabilities	13,222	12,584
Operating lease liabilities, net of current portion	25,964	28,032
Other noncurrent liabilities	179	320
Total liabilities	39,365	40,936
Commitments and contingencies (Note 10)
Stockholders’ equity:
Preferred stock, $0.00001 par value; 5,000,000 shares authorized as of December 31, 2023 and 2022; zero shares issued and outstanding as of December 31, 2023 and 2022	0	0
Additional paid-in capital	702,868	667,739
Accumulated other comprehensive loss	(192)	(1,251)
Accumulated deficit	(305,773)	(219,496)
Total stockholders’ equity	396,904	446,993
Total liabilities and stockholders’ equity	436,269	487,929
Class A common stock
Stockholders’ equity:
Common stock	1	1
Class B common stock
Stockholders’ equity:
Common stock	0	0
Nonrelated Party
Current assets:
Accounts receivable, net	4,831	4,315
Related Party
Current assets:
Accounts receivable, net	$ 559	$ 1,804

About Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Oregon Health & Science University; The Broad Institute of MIT and Harvard; Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

CEO	Dr. Omid C. Farokhzad M.D., Ph.D.
WEBSITE	https://seer.bio
INDUSTRY	Biotechnology
EMPLOYEES	164

Seer, Inc. Frequently Asked Questions

What is the ticker symbol for Seer, Inc.? What does SEER stand for in stocks?

SEER is the stock ticker symbol of Seer, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Seer, Inc. (SEER)?

As of Tue Apr 23 2024, market cap of Seer, Inc. is 115.57 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SEER stock?

You can check SEER's fair value in chart for subscribers.

What is the fair value of SEER stock?

You can check SEER's fair value in chart for subscribers. The fair value of Seer, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Seer, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for SEER so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Seer, Inc. a good stock to buy?

The fair value guage provides a quick view whether SEER is over valued or under valued. Whether Seer, Inc. is cheap or expensive depends on the assumptions which impact Seer, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SEER.

What is Seer, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, SEER's PE ratio (Price to Earnings) is -1.34 and Price to Sales (PS) ratio is 6.94. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SEER PE ratio will change depending on the future growth rate expectations of investors.